"The Federal Reserve is now caught in a classic stagflation trap: slashing rates risks reigniting inflation, yet raising them is impossible with a crumbling labor market. Stagnant growth paired with sticky prices is the likely outcome. In this environment, defensive names with pricing power and essential demand stand out."
"Cardinal Health is a global leader in healthcare services and products operating two main segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It delivers branded and generic pharmaceuticals, specialty drugs, over-the-counter products, and a vast array of medical and laboratory supplies to more than 90% of U.S. hospitals."
"In an era when healthcare spending continues to rise regardless of broader economic conditions, this steady, high-volume business model provides remarkable visibility into future cash flows. Its scale allows it to move 40,000 pharmaceutical deliveries daily and manage complex logistics that keep hospitals and pharmacies stocked around the clock."
A weak jobs report showing 92,000 nonfarm payroll losses and 4.4% unemployment creates a stagflation environment where the Federal Reserve faces conflicting pressures. Defensive stocks with pricing power and essential demand become attractive investments. Cardinal Health operates as a critical healthcare infrastructure provider, delivering pharmaceuticals and medical products to over 90% of U.S. hospitals and thousands of physician offices and pharmacies. The company reported 19% sales growth to $65.6 billion and matching earnings growth to $1.97 per share, with analysts forecasting 16% annual EPS growth over five years. Its high-volume business model managing 40,000 daily pharmaceutical deliveries provides visibility into future cash flows, while healthcare spending remains resilient regardless of broader economic conditions.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]